0209.HK
Winshine Science Company Limited [0209.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0209.HK Stock Summary
In the News
0209.HK Financial details
Company Rating
Sell
Market Cap
35.48M
Income
-20.57M
Revenue
1.37B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.51K
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
3.99
Forward P/E
-
PEG
-0.13
P/S
0.05
P/B
-0.36
P/C
-
P/FCF
1.78
Quick Ratio
0.12
Current Ratio
0.53
Debt / Equity
-3.02
LT Debt / Equity
-
-
-
EPS (TTM)
-0.05
EPS next Y
-
EPS next Q
-
EPS this Y
-387.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-11.92%
Revenue last 5Y
-4.23%
Revenue Q/Q
58.16%
EPS Q/Q
-72.36%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
2%
ROE
-9%
ROC
-0.13%
Gross Margin
12%
Oper. Margin
1%
Profit Margin
1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.049-0.166
52W High
-
52W Low
-
RSI
34
Rel Volume
2.16
Avg Volume
50.81K
Volume
110K
Perf Week
-13.11%
Perf Month
-43.62%
Perf Quarter
-
Perf Half Y
-32.91%
-
-
-
-
Beta
-0.583
-
-
Volatility
0%, 0.01%
Prev Close
0%
Price
0.053
Change
-10.17%
0209.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.77 | 0.99 | 1.98 | 2.32 | 1.16 | |
| Net income per share | -0.12 | -0.26 | -0.37 | 0.02 | -0.06 | |
| Operating cash flow per share | 0.02 | -0.16 | -0.09 | 0.06 | 0 | |
| Free cash flow per share | -0.02 | -0.18 | -0.12 | 0.03 | 0 | |
| Cash per share | 0.42 | 0.17 | 0.19 | 0.14 | 0.26 | |
| Book value per share | 0.33 | 0.1 | -0.27 | -0.24 | -0.18 | |
| Tangible book value per share | 0.33 | 0.1 | -0.27 | -0.24 | -0.18 | |
| Share holders equity per share | 0.33 | 0.1 | -0.27 | -0.24 | -0.18 | |
| Interest debt per share | 0.74 | 0.68 | 0.8 | 0.57 | 0.57 | |
| Market cap | 76.9M | 263.65M | 201.4M | 69.58M | 32.88M | |
| Enterprise value | 189.35M | 439.85M | 410.2M | 215.54M | 157.5M | |
| P/E ratio | -1.81 | -2.75 | -1.48 | 8.61 | -1.15 | |
| Price to sales ratio | 0.12 | 0.72 | 0.28 | 0.08 | 0.06 | |
| POCF ratio | 10.51 | -4.42 | -6.15 | 3.35 | 0 | |
| PFCF ratio | -9.12 | -4.03 | -4.76 | 6.35 | 0 | |
| P/B Ratio | 0.64 | 6.96 | -2.04 | -0.78 | -0.41 | |
| PTB ratio | 0.64 | 6.96 | -2.04 | -0.78 | -0.41 | |
| EV to sales | 0.29 | 1.21 | 0.57 | 0.25 | 0.3 | |
| Enterprise value over EBITDA | -23.88 | -9.11 | -12.11 | 13.76 | 169.91 | |
| EV to operating cash flow | 25.88 | -7.38 | -12.53 | 10.38 | 0 | |
| EV to free cash flow | -22.45 | -6.73 | -9.7 | 19.66 | 0 | |
| Earnings yield | -0.55 | -0.36 | -0.68 | 0.12 | -0.87 | |
| Free cash flow yield | -0.11 | -0.25 | -0.21 | 0.16 | 0 | |
| Debt to equity | 2.14 | 6.22 | -2.8 | -2.18 | -3.02 | |
| Debt to assets | 0.43 | 0.49 | 0.5 | 0.57 | 0.58 | |
| Net debt to EBITDA | -14.18 | -3.65 | -6.16 | 9.31 | 134.44 | |
| Current ratio | 0.84 | 0.53 | 0.62 | 0.53 | 0.61 | |
| Interest coverage | -1.45 | -4.6 | -3.22 | 0.38 | -0.78 | |
| Income quality | -0.17 | 0.62 | 0.24 | 2.57 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.11 | 0.16 | 0.09 | 0.08 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.24 | 0.31 | 0 | 0 | 0 | |
| Capex to operating cash flow | -2.15 | 0.1 | 0.29 | -0.47 | 0 | |
| Capex to revenue | -0.02 | -0.02 | -0.01 | -0.01 | 0 | |
| Capex to depreciation | -1.16 | -0.39 | -0.53 | -0.96 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.93 | 0.78 | 1.5 | 0.35 | 0.5 | |
| ROIC | -0.07 | -0.22 | -0.29 | 0.03 | -0.1 | |
| Return on tangible assets | -0.09 | -0.28 | -0.25 | 0.02 | -0.07 | |
| Graham Net | -0.58 | -0.8 | -1.15 | -0.78 | -0.63 | |
| Working capital | -65.65M | -200.24M | -232.44M | -192.77M | -185.18M | |
| Tangible asset value | -24.07M | -110.18M | -98.94M | -89.65M | -81.61M | |
| Net current asset value | -142.11M | -224.4M | -264.39M | -212M | -203.29M | |
| Invested capital | 2.14 | 6.22 | -2.8 | -2.18 | -3.02 | |
| Average receivables | 72.68M | 81.26M | 97.28M | 102.83M | 70.99M | |
| Average payables | 133.01M | 150.15M | 205.23M | 197.72M | 153.83M | |
| Average inventory | 78.48M | 81.77M | 106.35M | 100.74M | 79.97M | |
| Days sales outstanding | 57.39 | 60.52 | 67.58 | 30.74 | 49.16 | |
| Days payables outstanding | 94.12 | 160.58 | 137.17 | 66.62 | 128.61 | |
| Days of inventory on hand | 42.91 | 101.33 | 61.96 | 41.2 | 56.67 | |
| Receivables turnover | 6.36 | 6.03 | 5.4 | 11.87 | 7.42 | |
| Payables turnover | 3.88 | 2.27 | 2.66 | 5.48 | 2.84 | |
| Inventory turnover | 8.51 | 3.6 | 5.89 | 8.86 | 6.44 | |
| ROE | -0.35 | -2.53 | 1.37 | -0.09 | 0.36 | |
| Capex per share | -0.04 | -0.02 | -0.03 | -0.03 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.26 | 1.36 | 0.96 | 0.52 | 0 | |
| Net income per share | -0.29 | 0.04 | -0.01 | -0.05 | 0 | |
| Operating cash flow per share | 0.01 | -0.03 | 0.09 | -0.33 | 0 | |
| Free cash flow per share | -0.01 | -0.05 | 0.08 | -0.34 | 0 | |
| Cash per share | 0.19 | 0.13 | 0.14 | 0.1 | 0 | |
| Book value per share | -0.27 | -0.28 | -0.24 | -0.21 | 0 | |
| Tangible book value per share | -0.27 | -0.28 | -0.24 | -0.21 | 0 | |
| Share holders equity per share | -0.27 | -0.28 | -0.24 | -0.21 | 0 | |
| Interest debt per share | 0.78 | 0.74 | 0.55 | 0.66 | 0 | |
| Market cap | 201.4M | 106.19M | 69.58M | 54.32M | 0 | |
| Enterprise value | 410.2M | 321.9M | 215.54M | 268.03M | 124.63M | |
| P/E ratio | -0.48 | 2.04 | -3.54 | -0.65 | 0 | |
| Price to sales ratio | 0.44 | 0.21 | 0.2 | 0.27 | 0 | |
| POCF ratio | 66.6 | -8.29 | 2.07 | -0.42 | 0 | |
| PFCF ratio | -94.56 | -5.61 | 2.33 | -0.41 | 0 | |
| P/B Ratio | -2.04 | -1.05 | -0.78 | -0.67 | 0 | |
| PTB ratio | -2.04 | -1.05 | -0.78 | -0.67 | 0 | |
| EV to sales | 0.89 | 0.65 | 0.61 | 1.32 | 0.39 | |
| Enterprise value over EBITDA | -29.55 | 10.1 | -13.29 | -21.79 | 13.32 | |
| EV to operating cash flow | 135.65 | -25.14 | 6.42 | -2.07 | 0 | |
| EV to free cash flow | -192.58 | -17 | 7.21 | -2.01 | 0 | |
| Earnings yield | -0.52 | 0.12 | -0.07 | -0.39 | 0 | |
| Free cash flow yield | -0.01 | -0.18 | 0.43 | -2.46 | 0 | |
| Debt to equity | -2.8 | -2.61 | -2.18 | -3.11 | -3.02 | |
| Debt to assets | 0.5 | 0.39 | 0.57 | 0.59 | 0.58 | |
| Net debt to EBITDA | -15.04 | 6.77 | -9 | -17.37 | 13.32 | |
| Current ratio | 0.62 | 0.73 | 0.53 | 0.63 | 0.61 | |
| Interest coverage | -2.78 | 3.11 | -2.66 | -2.91 | 0.35 | |
| Income quality | -0.03 | -0.99 | -6.84 | 6.16 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.09 | 0.08 | 0.07 | 0.12 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.7 | 0.48 | -0.11 | 0.03 | 0 | |
| Capex to revenue | -0.01 | -0.01 | -0.01 | -0.02 | 0 | |
| Capex to depreciation | -0.51 | -0.73 | -1.97 | -0.55 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.32 | 0.47 | 0.27 | 0.5 | 0 | |
| ROIC | -0.14 | 0.13 | -0.48 | -0.11 | 0.08 | |
| Return on tangible assets | -0.19 | 0.02 | -0.01 | -0.05 | -0.02 | |
| Graham Net | -1.15 | -1.27 | -0.78 | -0.81 | 0 | |
| Working capital | -232.44M | -202.35M | -192.77M | -179.88M | -185.18M | |
| Tangible asset value | -98.94M | -101.03M | -89.65M | -82.22M | -81.61M | |
| Net current asset value | -264.39M | -234.38M | -212M | -200.66M | -203.29M | |
| Invested capital | -2.8 | -2.61 | -2.18 | -3.11 | -3.02 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 26.18 | 40.84 | 18.29 | 56.87 | 19.79 | |
| Days payables outstanding | 54.06 | 82.65 | 37.6 | 80.07 | 52.52 | |
| Days of inventory on hand | 24.42 | 40.35 | 23.25 | 51.54 | 23.14 | |
| Receivables turnover | 3.44 | 2.2 | 4.92 | 1.58 | 4.55 | |
| Payables turnover | 1.66 | 1.09 | 2.39 | 1.12 | 1.71 | |
| Inventory turnover | 3.69 | 2.23 | 3.87 | 1.75 | 3.89 | |
| ROE | 1.06 | -0.13 | 0.05 | 0.26 | 0.09 | |
| Capex per share | -0.01 | -0.02 | -0.01 | -0.01 | 0 |
0209.HK Frequently Asked Questions
What is Winshine Science Company Limited stock symbol ?
Winshine Science Company Limited is a HK stock and trading under the symbol 0209.HK
What is Winshine Science Company Limited stock quote today ?
Winshine Science Company Limited stock price is $0.053 today.
Is Winshine Science Company Limited stock public?
Yes, Winshine Science Company Limited is a publicly traded company.
Company Profile
- Volume Average 50.81K
- Market Capitalization 35.48M
- Employee 1.51K
- CEO Mr. Zudian Weng
- Headquarters Admiralty,HK
- IPO Date 2002-03-06
-
Website
https://www.winshine.com 
Winshine Science Company Limited, an investment holding company, manufactures and trades in hard and stuffed toys in Hong Kong, the People's Republic of China, the United States, Europe, and Korea. The company operates in three segments: Securities Investments, Toys, and Medical and Health. It engages in the securities investment and trading activities; provision of credit finance and management services; property leasing activities; and research and development of medical and health technology solutions. The company was formerly known as Winshine Entertainment & Media Holding Company Limited and changed its name to Winshine Science Company Limited in February 2016. The company was incorporated in 2001 and is headquartered in Admiralty, Hong Kong.
